B. Riley FBR downgraded Adamis Pharmaceuticals Corp (NASDAQ:ADMP) to “sell” from “neutral,” and lowered its price target to $1.10 from $1.90 — a 25% discount to last night’s close. In reaction, the …

More Analyst: Time to Sell This Penny Stock Videos